Complex PCI in Octogenarian

The octogenarian population has already reached 137 million and continues to grow. It is estimated to triple by 2050. 

La estrategia invasiva en pacientes frágiles es segura

This increase represents a big challenge, seeing as these patients are often more fragile, present more complex coronary artery disease and multiple comorbidities. This generally requires two or more procedures and more experience both from operators and the whole health team. 

2,657 octogenarian patients were randomized, 1,387 received complex percutaneous coronary intervention (C PCI).

Primary end point was a composite of all-cause mortality, myocardial infarction (MI) or target vessel revascularization (TVR) (MACE) at 12 months.

Mean patient age was 84, with 36% diabetic and no significant differences in kidney function. Those receiving complex PCI were more often women, smoker, hypertensive, with dyslipidemia, prior MI, prior PCI, prior CABS, atrial fibrillation and lower ejection fraction. 

Read also: High Gradients After Valve-in-Valve.

The most frequent clinical presentation was stable chronic angina, followed by unstable angina, non-ST elevation acute MI (NTEMI), ST elevation MI (STEMI), and, less frequently, silent ischemia. 

Most procedures were femoral (84%). Patients with C PCI commonly presented left main lesions, multivessel disease, lesions to the anterior descending, calcified lesions, bifurcations, longer lesions, more stents, longer stents and the need for ventricular assistance, as well as higher SYNTAX score (20.8 vs. 10.7, p<0.001).

Read also: Glycemic Control and Coronary Stent Failure.

Primary end point resulted higher in patients undergoing C PCI (16.6% vs. 11.1%, p<0.001), as well as MI incidence (4.1% vs. 1.5%, p=0.002) and TVR (8.9% vs. 4.4%, p<0.001), with no differences in all-cause mortality. Also these patients presented a higher incidence of TLR and major bleeding with no differences in post discharge stroke or major bleeding incidence. 

Conclusion

Octogenarian undergoing complex PCI are associated to higher risk of major adverse cardiovascular events (MACE) at one year, because of higher MI and TVF rate, as well as higher incidenc of major bleeding, with no difference in all-cause mortality vs. pateints undergoing non-complex PCI. We should implement strategies to reduce complications in octogenarian patients undergoing complex PCI. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Prevalence and prognostic impact of complex percutaneous coronary intervention among octogenarians. 

Reference: Alessandro Spirito, et al. Catheter Cardiovasc Interv. 2024;103:1079–1087.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...